Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
2012 Dec 27
5)31)24-13-14-25-21(8-7-15-28(24
Pharmacological characterization of a novel cannabinoid ligand
MK-8033 hydrochloride
InChi: InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11
TAK-593 - CAS# 1005780-62-0 ifluorothymidine 2012 Dec 27TAK 593 is a n oral formulation containing a small molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet derived growth factor receptor (PDGFR) with potential antineoplastic activity. TAK 593 selectively binds to and inhibits VEGFR and PDGFR, which may result in the inhibition of angiogenesis and tumor cell proliferation. Product information CAS Number: 1005780 62 0 Molecular Weight: 445.
US$ 55.00
US$ 120.00
US$ 148.00
US$ 148.00
US$ 85.00
US$ 499999.50
US$ 90.00
US$ 48.00
US$ 55.00
US$ 15.00
US$ 499999.50